Cellergy is producing a large quantity of mitochondrial product from human primary sources for systemic, repeated administration, using fully matched allogeneic purified mitochondria delivered via IV for major systemic indications such as CNS disorders, muscle degeneration, and aging. Its breakthrough approach harnesses the power of young, healthy mitochondria to revolutionize the treatment of degenerative and metabolic diseases. Through innovative mitochondrial transplantation therapy, Cellergy replaces compromised mitochondria with fully functional ones, effectively restoring cellular energy production and enhancing cell function. The company is transforming human health by providing the power of young and healthy mitochondria to energize cells, fight degenerative diseases and enhance healthy longevity.